Sheep virus vaccine takes on COVID-19 as booster
NCT ID NCT05389319
First seen Apr 09, 2026 · Last updated May 15, 2026 · Updated 9 times
Summary
This early-stage study tests a new type of COVID-19 booster vaccine made from a harmless sheep virus. It aims to see if it is safe and boosts the immune system in healthy adults aged 18 to 55 who have already been vaccinated or infected. The study will enroll 96 people and look for side effects and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bernhard-Nocht-Institut für Tropenmedizin
RECRUITINGHamburg, Free and Hanseatic City of Hamburg, 20359, Germany
Contact Email: •••••@•••••
-
University Hospital Tübingen, Institute of Tropical Medicine
RECRUITINGTübingen, Baden-Wurttemberg, 72074, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.